Literature DB >> 22815389

Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD.

Bram van den Borst1, Ilse G M Slot, Valéry A C V Hellwig, Bettine A H Vosse, Marco C J M Kelders, Esther Barreiro, Annemie M W J Schols, Harry R Gosker.   

Abstract

Being well-established in advanced chronic obstructive pulmonary disease (COPD), skeletal muscle dysfunction and its underlying pathology have been scarcely investigated in patients with mild-to-moderate airflow obstruction. We hypothesized that a loss of oxidative phenotype (oxphen) associated with decreased endurance is present in the skeletal muscle of patients with mild-to-moderate COPD. In quadriceps muscle biopsies from 29 patients with COPD (forced expiratory volume in 1 s [FEV1] 58 ± 16%pred, body mass index [BMI] 26 ± 4 kg/m(2)) and 15 controls (BMI 25 ± 3 kg/m(2)) we assessed fiber type distribution, fiber cross-sectional areas (CSA), oxidative and glycolytic gene expression, OXPHOS protein levels, metabolic enzyme activity, and levels of oxidative stress markers. Quadriceps function was assessed by isokinetic dynamometry, body composition by dual-energy X-ray absorptiometry, exercise capacity by an incremental load test, and physical activity level by accelerometry. Compared with controls, patients had comparable fat-free mass index, quadriceps strength, and fiber CSA, but quadriceps endurance was decreased by 29% (P = 0.002). Patients with COPD had a clear loss of muscle oxphen: a fiber type I-to-II shift, decreased levels of OXPHOS complexes IV and V subunits (47% and 31%, respectively; P < 0.05), a decreased ratio of 3-hydroxyacyl-CoA dehydrogenase/phosphofructokinase (PFK) enzyme activities (38%, P < 0.05), and decreased peroxisome proliferator-activated receptor-γ coactivator-1α (40%; P < 0.001) vs. increased PFK (67%; P < 0.001) gene expression levels. Within the patient group, markers of oxphen were significantly positively correlated with quadriceps endurance and inversely with the increase in plasma lactate relative to work rate during the incremental test. Levels of protein carbonylation, tyrosine nitration, and malondialdehyde protein adducts were comparable between patients and controls. However, among patients, oxidative stress levels were significantly inversely correlated with markers of oxphen and quadriceps endurance. Reduced muscle endurance associated with underlying loss of muscle oxphen is already present in patients with mild-to-moderate COPD without muscle wasting.

Entities:  

Keywords:  muscle wasting; oxidative capacity; physical activity; quadriceps endurance

Mesh:

Substances:

Year:  2012        PMID: 22815389     DOI: 10.1152/japplphysiol.00508.2012

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  38 in total

Review 1.  Pathophysiology of human ventilatory control.

Authors:  Jerome A Dempsey; Curtis A Smith
Journal:  Eur Respir J       Date:  2014-06-12       Impact factor: 16.671

2.  Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.

Authors:  Michael J Toth; Mark S Miller; Damien M Callahan; Andrew P Sweeny; Ivette Nunez; Steven M Grunberg; Hirak Der-Torossian; Marion E Couch; Kim Dittus
Journal:  J Appl Physiol (1985)       Date:  2013-02-14

Review 3.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

4.  Altered skeletal muscle mitochondrial phenotype in COPD: disease vs. disuse.

Authors:  Jayson R Gifford; Joel D Trinity; Oh-Sung Kwon; Gwenael Layec; Ryan S Garten; Song-Young Park; Ashley D Nelson; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2017-12-28

Review 5.  Impaired regenerative capacity contributes to skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Ariel Jaitovich
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-22       Impact factor: 5.282

Review 6.  Integrating Mechanisms of Exacerbated Atrophy and Other Adverse Skeletal Muscle Impact in COPD.

Authors:  Tanja Taivassalo; Russell T Hepple
Journal:  Front Physiol       Date:  2022-06-03       Impact factor: 4.755

7.  Adaptive remodeling of skeletal muscle energy metabolism in high-altitude hypoxia: Lessons from AltitudeOmics.

Authors:  Adam J Chicco; Catherine H Le; Erich Gnaiger; Hans C Dreyer; Jonathan B Muyskens; Angelo D'Alessandro; Travis Nemkov; Austin D Hocker; Jessica E Prenni; Lisa M Wolfe; Nathan M Sindt; Andrew T Lovering; Andrew W Subudhi; Robert C Roach
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

8.  Association between quadriceps strength and self-reported physical activity in people with knee osteoarthritis.

Authors:  Brian Pietrosimone; Abbey C Thomas; Susan A Saliba; Christopher D Ingersoll
Journal:  Int J Sports Phys Ther       Date:  2014-05

9.  MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-acquired Weakness.

Authors:  Roser Farre Garros; Richard Paul; Martin Connolly; Amy Lewis; Benjamin E Garfield; S Amanda Natanek; Susannah Bloch; Vincent Mouly; Mark J Griffiths; Michael I Polkey; Paul R Kemp
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

10.  SDH Subunit C Regulates Muscle Oxygen Consumption and Fatigability in an Animal Model of Pulmonary Emphysema.

Authors:  Joseph Balnis; Lisa A Drake; Catherine E Vincent; Tanner C Korponay; Diane V Singer; David Lacomis; Chun Geun Lee; Jack A Elias; David Jourd'heuil; Harold A Singer; Ariel Jaitovich
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.